Blood pressure variability and neuroplasticity in patients with type 2 diabetes mellitus

Close metadata

OBJECTIVE

Analysis of the role of blood pressure (BP) variability in the formation of neuroplasticity in patients with type 2 diabetes mellitus (DM).

MATERIAL AND METHODS

100 patients with type 2 DM were examined, which were divided into groups depending on the presence of cognitive impairment (CI), the control group consisted of 25 people. All examined patients underwent a clinical examination, a standard set of biochemical blood tests, plasma osteopontin levels, 24-hour blood pressure monitoring (ABPM) for 24—26 h MRI of the brain (dynamic contrast and arterial spin marks, proton spectroscopy, tractography).

RESULTS

Patients with type 2 diabetes and CI had higher body mass index, blood levels of glycated hemoglobin, glucose, alanine aminotransferase, low-density lipoprotein, triglycerides, total cholesterol, osteopontin, and lower levels of high-density lipoprotein (p≤0.05). The level of osteopontin was higher in patients with overweight, hyperglycemia, dyslipidemia, and in patients with CI in patients with BP variability. When assessing 24-hour blood pressure monitoring (ABPM), a significant difference was found in all standard indicators, while patients with type 2 diabetes were referred to as «non-dipper», in the presence of CI they noted significantly higher values of the index of time and area of stay in the suprathreshold state. BP and variability in SBP and DBP at night, as well as the risk of occult hypertension. A decrease in cerebral blood flow was revealed according to the data of contrast and non-contrast assessment of perfusion in cortical (especially in the frontal lobe) and subcortical (mainly in the putamen) structures, associated with changes in ABPM parameters. Mean SBP and DBP day and night, as well as the index of BP variability, also affect the integrity of the corticospinal, uncinate, lower longitudinal tracts, and arcuate fasciculus. The same parameters change the metabolism of the hippocampus in terms of choline (Cho), creatine (Cr), creatine phosphate (Cr2), as well as the ratio of N-acetylaspartate (NAA)/Cho, NAA/Cr, Cho/Cr.

CONCLUSION

In patients with type 2 diabetes, BP variability contributes to the formation of CI through a pro-inflammatory mechanism (osteopontin), leading to impaired brain vascularization in general, white matter structure, and hippocampal metabolism.

Keywords:

type 2 diabetes mellitus

arterial hypertension

variability

osteopontin

magnetic resonance perfusion

magnetic resonance spectroscopy

tractography

Authors:

Matveeva M.V.

Siberian State Medical University

Samoilova Y.G.

Siberian State Medical University

Kudlay D.A.

Institute of Immunology;
Sechenov First Moscow State Medical University (Sechenov University)

Received:

21.01.2022

Accepted:

25.01.2022

List of references:

Gorelick PB. Blood pressure and the prevention of cognitive impairment. JAMA Neurol. 2014;71:1211-1213. https://doi.org/10.1001/jamaneurol.2014.2014
Elias PK, DAgostino RB, Elias MF, Wolf PA. Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp Aging Res. 1995;21:393-417. https://doi.org/10.1080/03610739508253992.
Sharipova GH, Chazova IE, Zhernakova JuV. Study of cognitive brain function in patients with arterial hypertension with or without metabolic syndrome. Sistemnye Gipertenzii. 2013;10(3):66-70. (In Russ.). https://doi.org/10.26442/SG28981
Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure related cognitive decline: does age make a difference? Hypertension. 2004;44:631-636. https://doi.org/10.1161/01.HYP.0000145858.07252.99
Pavlou DI, Paschou SA, Anagnostis P, et al. Hypertension in patients with type 2 diabetes mellitus: Targets and management. Maturitas. 2018;112:71-77. https://doi.org/10.1016/j.maturitas.2018.03.013
van Sloten TT, Sedaghat S, Carnethon MR, et al. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8(4):325-336. https://doi.org/10.1016/S2213-8587(19)30405-X
Wolak T. Osteopontin — a multi-modal marker and mediator in atherosclerotic vascular disease. Atherosclerosis. 2014;236(2):327-337. https://doi.org/10.1016/j.atherosclerosis.2014.07.004
Sun Y, Yin XS, Guo H, et al. Elevated osteopontin levels in mild cognitive impairment and Alzheimer’s disease. Mediators Inflamm. 2013;2013:615745. https://doi.org/10.1155/2013/615745
van den Berg E, Kloppenborg RP, Kessels RP, et al. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta. 2009;1792(5):470-481. https://doi.org/10.1016/j.bbadis.2008.09.004
Samoilova IG, Rotkank MA, Zhukova NG, et al. Variability of glycemia in patients with type 1 diabetes mellitus: the relationship with cognitive dysfunction and the results of magnetic resonance imaging. Problemy Jendokrinologii. 2018;64(5):286-291. (In Russ.). https://doi.org/10.14341/probl9589
Samoilova IuG, Rotkank MA, Zhukova NG, et al. Markers for cognitive impairments and variability of glycaemia in patients with type 1 diabetes mellitus. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(4):48-51. (In Russ.). https://doi.org/10.17116/jnevro20181184148-51
Kahles F, Findeisen HM, Bruemmer D. Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. Mol Metab. 2014;3(4):384-393. https://doi.org/10.1016/j.molmet.2014.03.004
Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clin Biochem. 2018;59:17-24. https://doi.org/10.1016/j.clinbiochem.2018.07.003
Czuriga-Kovács KR, Czuriga D, Csiba L. Influence of Hypertension, Alone and in Combination with Other Vascular Risk Factors on Cognition. CNS Neurol Disord Drug Targets. 2016;15(6):690-698. https://doi.org/10.2174/1871527315666160518122721
Algorithms of specialised medical care for diabetic patients. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. Issue 9 (supplemented). M. 2019. (In Russ.). https://doi.org/10.14341/DM221S1
Samoilova YG, Matveeva MV, Tonkikh OS, Fimushkina NY. Perfusion of the brain in type 1 diabetes mellitus and cognitive dysfunction. Medicinskaja Vizualizacija. 2021;25(3):66-72. (In Russ.). https://doi.org/10.24835/1607-0763-940
Samoilova YG, Matveeva MV, Tonkikh OS, et al. Tractography of the brain in diabetes and cognitive disorders. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2020;120(10):33-37. (In Russ.). https://doi.org/10.17116/jnevro202012010133
Chen YC, Li YH, Lu J, et al. Correlation Between the Reduction in Lenticulostriate Arteries Caused by Hypertension and Changes in Brain Metabolism Detected With MRI. AJR Am J Roentgenol. 2016;206(2):395-400. https://doi.org/10.2214/AJR.15.14514

Close metadata